Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Parkinson's disease: fetal cell or stem cell-derived treatments

Research output: Contribution to journalJournal articleResearchpeer-review

  1. Hyperthyroidism in pregnancy

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Hypothyroidism (primary)

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Hyperthyroidism (primary)

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Cerebral infarction after fractionated stereotactic radiation therapy of benign anterior skull base tumors

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Parkinson's disease: fetal cell or stem cell derived treatments

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

INTRODUCTION: The mean age of onset of Parkinson's disease is about 65 years, with a median time of 9 years between diagnosis and death.

METHODS AND OUTCOMES: We conducted a systematic review and aimed to answer the following clinical question: What are the effects of fetal cell or stem cell-derived therapy in people with Parkinson's disease? We searched: Medline, Embase, The Cochrane Library and other important databases up to September 2014 (Clinical Evidence reviews are updated periodically; please check our website for the most up-to-date version of this review). We included harms alerts from relevant organisations such as the US Food and Drug Administration (FDA) and the UK Medicines and Healthcare products Regulatory Agency (MHRA).

RESULTS: We found two studies that met our inclusion criteria. We performed a GRADE evaluation of the quality of evidence for interventions.

CONCLUSIONS: In this systematic review we present information relating to the effectiveness and safety of the following interventions: fetal cell therapy versus deep brain stimulation; fetal cell therapy versus sham surgery; stem cell-derived therapy versus deep brain stimulation; stem cell-derived therapy versus sham surgery.

Original languageEnglish
JournalClinical Evidence (Online)
Volume2015
ISSN1752-8526
Publication statusPublished - 2015

ID: 45964439